How a Dutch AI Startup is Quietly Reshaping Hearing Healthcare

Jan de Vries · 2026-08-28

Let's talk about a quiet revolution happening in the hearing care industry. You know, it's one of those areas where technology hasn't really kept pace with human need. That's where a startup from Maastricht is stepping in, and they just secured some serious backing to do it. Clementine, also known as ClementineAI, just closed a $2 million Seed round. The funding was led by Healthy.Capital, an Amsterdam-based HealthTech investor with a sharp eye for promising ventures. They've backed companies like Pharmi and OpenUp, so their vote of confidence here is meaningful. ### The Problem It's Solving Think about this for a second. Hearing loss affects an estimated 1.5 billion people globally. That's a staggering number. But here's the kicker—nearly 80% of those people never seek treatment. And the ones who finally do? They typically wait over eight years to take that first step. Eight years! That's a huge gap between need and action. Why does this happen? There are emotional barriers, practical hurdles, and frankly, the process can feel intimidating. Clinics are busy, waiting lists are long, and starting the conversation is hard. ### Meet Matthew, The AI Agent Clementine's platform is built around a core innovation they call Matthew. No, it's not a person—it's an AI hearing care agent. This is the world's first AI hearing activation platform built specifically for this industry. Matthew's job is to engage directly with prospective patients, 24/7. It answers questions without judgment, educates users, and gently guides them toward appropriate care. It's like having a knowledgeable, endlessly patient companion for that initial, often-daunting, step. "Clinics don't need more leads; they need better conversations at the right moment," says Vince van de Weijer, founder and CEO of Clementine. "Matthew ensures no patient inquiry goes unanswered." ### Why Investors Are Betting on This Douwe Jippes, managing partner at Healthy.Capital, put it well. "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with healthcare." The key here is the blend of AI with behavioral science. It's not just a chatbot. It's designed to understand the emotional journey and break down those barriers that keep people from seeking help. - For clinics: Matthew handles initial inquiries, eliminates admin work, and turns calls into actual bookings. - For patients: It offers streamlined, judgment-free communication, aiming for better hearing outcomes from the very start. ### The Road Ahead This funding comes at a pivotal time. The company recently expanded its commercial reach through a partnership with Zoolstra, a marketing agency that serves hearing clinics across the United States and Canada. That's a significant North American foothold. The new capital has a clear purpose. Clementine plans to deepen its AI capabilities and expand partnerships—not just with hearing clinics, but also with optical retailers and other healthcare organizations. They're looking to integrate hearing care into broader health conversations. It's a fascinating case of European innovation tackling a global, human-scale problem. They're not just building another SaaS tool; they're trying to rebuild the on-ramp to essential care for millions. And with $2 million in fresh fuel, they're ready to turn up the volume.